In the context of ICI-therapy MUC4 has been proposed as a novel tumor-associated antigen in pancreatic cancer (47), while in colorectal cancer, MUC4-mutation was found to be associated with high TMB and increased T-cell infiltration (48). This evidence concerns the gene MUC4 and pancreatic neoplasm.